InvestorsHub Logo
Followers 4
Posts 171
Boards Moderated 0
Alias Born 03/02/2015

Re: None

Wednesday, 05/11/2022 11:27:10 AM

Wednesday, May 11, 2022 11:27:10 AM

Post# of 863
OTLK - Corporate Presentation MAY 2022
Good News all as planned
U.S. FDA BLA submitted March 2022 with anticipated approval to follow 9-12 months later.
Sufficient capital through the anticipated approval of the ONS-5010 BLA.

SOURCE:
https://ir.outlooktherapeutics.com/static-files/7590f061-6751-4f3e-89a3-c2101f211735
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OTLK News